Cardiovascular risk factors in chronic obstructive pulmonary disease:: Results of the ARCE study

被引:35
作者
de Lucas-Ramos, Pilar [1 ]
Luis Izquierdo-Alonso, Jose [2 ]
Rodriguez-Gonzalez Moro, Jose Miguel [1 ]
Maria Bellon-Cano, Jose [3 ]
Ancochea-Bermudez, Julio [4 ]
Calle-Rubio, Myrian [5 ]
Calvo-Corbella, Eduardo [6 ]
Molina-Paris, Jesus [7 ]
Perez-Rodriguez, Esteban [8 ]
Pons, Sonia [9 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Serv Neumol, Madrid 28007, Spain
[2] Univ Hosp, Serv Neumol, Guadalajara, Spain
[3] Hosp Gen Univ Gregorio Maranon, Unidad Invest, Madrid 28007, Spain
[4] Hosp Univ La Princesa, Serv Neumol, Madrid, Spain
[5] Hosp Univ Clin San Carlos, Serv Neumol, Madrid, Spain
[6] Univ Pozuelo Alarcon, Ctr Salud, Madrid, Spain
[7] Ctr Salud Francia, Madrid, Spain
[8] Hosp Univ Ramon & Cajal, Serv Neumol, Madrid 28007, Spain
[9] Dept Med, Labs Esteve, Barcelona, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2008年 / 44卷 / 05期
关键词
COPD; cardiovascular risk; prevalence;
D O I
10.1016/S1579-2129(08)60037-3
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OBJECTIVE: Cardiovascular disease is a common cause of death in patients with chronic obstructive pulmonary disease (COPD). It is not clear whether the high cardiovascular comorbidity is due to an increase in traditional risk factors or whether, in contrast, COPD can be considered an independent risk factor. The aim of this study was to analyze the prevalence of risk factors and cardiovascular comorbidity in a community-based population treated for COPD. PATIENTS AND METHODS: This was a concurrent multicenter, cross-sectional study that included 572 patients with confirmed diagnosis of COPD. Information on cardiovascular risk factors and comorbidity was collected by extracting data from the medical records of the participating center. RESULTS: The mean (SD) forced expiratory volume in 1 second (FEV1) was 53.7% (16.85%) of predicted and the ratio of FEV1 to forced vital capacity was 57.9% (10.9%). Hypertension was reported in 53%, obesity in 27%, dyslipidemia in 26%, and diabetes in 23% of the patients. The prevalence of risk factors was not related to disease severity, but there was a trend towards an association with age. In the study group, 16.4% had ischemic heart disease, 7% cerebrovascular disease, and 17% peripheral vascular disease. Cardiovascular disease was not associated with COPD severity, but such an association was reported for age and traditional risk factors. CONCLUSIONS: Cardiovascular risk factors are highly prevalent in patients with COPD. The prevalence of cardiovascular and cerebrovascular disease exceeds that reported in the general population. No relationship was found between the severity of airflow obstruction and the presence of cardiovascular comorbidity.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 29 条
[1]
Alonso JLI, 2005, ARCH BRONCONEUMOL, V41, P410
[2]
ALVAREZ FV, 2005, ENFERMEDAD CARDIOVAS
[3]
The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial [J].
Anthonisen, NR ;
Skeans, MA ;
Wise, RA ;
Manfreda, J ;
Kanner, RE ;
Connett, JE .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :233-239
[4]
ANTONELLIINCALZ. R, 1997, EUR RESP J, V10, P2794
[5]
Prevalence of obesity in Spain:: Results of the SEEDO 2000 study [J].
Aranceta, J ;
Rodrigo, CP ;
Majem, LS ;
Barba, LR ;
Izquierdo, JQ ;
Vioque, J ;
Marí, JT ;
Verdú, JM ;
González, JL ;
Tojo, R ;
Sala, MF .
MEDICINA CLINICA, 2003, 120 (16) :608-612
[6]
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[7]
Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study [J].
Castell, C ;
Tresserras, R ;
Serra, J ;
Goday, A ;
Lloveras, G ;
Salleras, L .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 43 (01) :33-40
[8]
Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients [J].
Curkendall, SM ;
DeLuise, C ;
Jones, JK ;
Lanes, S ;
Stang, MR ;
Goehring, E ;
She, DW .
ANNALS OF EPIDEMIOLOGY, 2006, 16 (01) :63-70
[9]
Chronic obstructive pulmonary disease severity and cardiovascular outcomes [J].
Curkendall, Suellen M. ;
Lanes, Stephan ;
de Luise, Cynthia ;
Stang, Mary Rose ;
Jones, Judith K. ;
She, Dewei ;
Goehring, Earl, Jr. .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 (11) :803-813
[10]
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients [J].
de Torres, JP ;
Cordoba-Lanus, E ;
López-Aguilar, C ;
de Fuentes, MM ;
de Garcini, AM ;
Aguirre-Jaime, A ;
Celli, BR ;
Casanova, C .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (05) :902-907